Goldman Sachs Group Inc. Decreases Position in Israel Chemicals (ICL)
Goldman Sachs Group Inc. cut its position in shares of Israel Chemicals (NYSE:ICL) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,635,412 shares of the basic materials company’s stock after selling 856,715 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Israel Chemicals were worth $30,848,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Stevens Capital Management LP bought a new position in shares of Israel Chemicals during the third quarter worth about $105,000. Amundi Pioneer Asset Management Inc. bought a new position in shares of Israel Chemicals during the fourth quarter worth about $171,000. Geode Capital Management LLC bought a new position in shares of Israel Chemicals during the fourth quarter worth about $182,000. Citadel Advisors LLC bought a new position in shares of Israel Chemicals during the third quarter worth about $214,000. Finally, Russell Investments Group Ltd. grew its holdings in shares of Israel Chemicals by 117.2% during the third quarter. Russell Investments Group Ltd. now owns 88,128 shares of the basic materials company’s stock worth $390,000 after buying an additional 47,562 shares in the last quarter. Institutional investors and hedge funds own 7.96% of the company’s stock.
Israel Chemicals (ICL) opened at $4.22 on Friday. Israel Chemicals has a 52-week low of $3.85 and a 52-week high of $4.95. The company has a current ratio of 1.17, a quick ratio of 0.64 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $5,733.07, a P/E ratio of 14.67 and a beta of 1.06.
A number of research analysts recently issued reports on ICL shares. Zacks Investment Research upgraded Israel Chemicals from a “sell” rating to a “hold” rating in a report on Thursday, February 1st. Citigroup upgraded Israel Chemicals from a “neutral” rating to a “buy” rating in a report on Wednesday. TheStreet upgraded Israel Chemicals from a “c+” rating to a “b-” rating in a report on Friday, March 9th. Finally, ValuEngine raised Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $5.00.
Israel Chemicals Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals (NYSE:ICL).
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.